Disease Name:

Non-Alcoholic Fatty Liver Disease

microRNA Score: 0.0302

Gene Score: 0.0213

Pathway Score: 0.0574

Micro RNA Tissue/ Cell line MicroRNA regulation Targeted Member Pathway More Details References
hsa-miR-34a L-02 Up SIRT1 Lipid metabolism pathway Overexpression of miR-34a suppresses the expression of SIRT1. Down-regulation of miR-34a is associated with altered lipid metabolism in non-alcoholic fatty liver disease.
Ding et al., 2015
hsa-miR-34a L-02 Up PPARA Lipid metabolism pathway Overexpression of miR-34a suppresses the expression of PPAR-alpha. Down-regulation of miR-34a is associated with altered lipid metabolism in non-alcoholic fatty liver disease.
Ding et al., 2015
hsa-miR-21 Hep-G2 Up HBP1 p53 signaling pathway MicroRNA-21 induces hepatic lipid accumulation through targeting Hbp1-p53-Srebp1c pathway.
Wu et al., 2015
hsa-miR-34a Hepatocyte Up HNF4 ALPHA Lipid metabolism pathway MicroRNA-34a suppresses very low-density lipoprotein secretion and induces liver steatosis and hypolipidemia through the miR-34a-HNF4-alpha pathway.
Xu et al., 2015
hsa-miR-451 Hep-G2 Down CAB39 PI3K-Akt signaling pathway Decreased expression of microRNA-451 is associated with suppression fatty acid-induced proinflammatory cytokine production via the AMPK/PI3K-Akt signaling pathway.
Hur et al., 2015
hsa-miR-199a Hep-G2 Up CAV1 PPAR signaling pathway Overexpression of miR199a in hepatocytes is associated with impaired FA beta-oxidation in mitochondria and aberrant lipid deposits through the PPAR signaling pathway.
Li et al., 2014
hsa-miR-21 Hep-G2 Up HBP1 p53 signaling pathway Downregulation of hsa-miR-21 increases expression of HBP1 and p53 and decreased lipogenesis. miR-21 stimulates hepatic lipid accumulation and cancer development through modulation of Hbp1-p53-Srebp1c pathway.
Wu et al., 2015